Rosalind Advisors, Inc. 13D and 13G filings for PhaseBio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:12 pm Sale |
2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Rosalind Advisors, Inc. | 707,467 1.500% |
-1,900,390 (-72.87%) |
Filing |
| 2021-05-19 2:25 pm Purchase |
2021-05-12 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Rosalind Advisors, Inc. | 2,607,857 5.400% |
2,607,857 (New Position) |
Filing |